...
首页> 外文期刊>Journal of neurointerventional surgery >Technical, angiographic and clinical outcomes of Neuroform 1, 2, 2 Treo and 3 devices in stent-assisted coiling of intracranial aneurysms
【24h】

Technical, angiographic and clinical outcomes of Neuroform 1, 2, 2 Treo and 3 devices in stent-assisted coiling of intracranial aneurysms

机译:Neuroform 1、2、2 Treo和3装置在颅内动脉瘤支架辅助卷绕中的技术,血管造影和临床结果

获取原文
获取原文并翻译 | 示例
           

摘要

Background and purpose: Since 2002 the Neuroform stent has expanded endovascular treatment of widenecked intracranial aneurysms. A study was undertaken to assess the technical success rates and angiographic and clinical outcomes in stent-assisted coiling with Neuroform 1, 2, 2 Treo and 3. Methods: Patients undergoing Neuroform stent-assisted coiling were enrolled in a prospective registry that included 156 stent deployment attempts in 113 consecutive patients (mean age 53, range 25-78). Deployment success and difficulty, stent movement, procedural complications, immediate/delayed aneurysm occlusion and in-stent stenosis on angiographic follow-up were compared among Neuroform 1, 2, 2 Treo and 3 stents using a log likelihood ratio χ 2 test. Results: Of 156 stent attempts, 123 (79%) were deployed (Neuroform 1: 8/9 (89%), Neuroform 2: 50/66 (76%), Neuroform 2 Treo: 9/11 (82%), Neuroform 3: 56/70 (80%)) with a symptomatic complication rate of 1.9% (3/156; 2 transient ischemic attacks, 1 stroke, no deaths). Non-target stent placement (1/8 (13%), 6/50 (12%), 2/9 (22%), 3/56 (5%)), difficult placement (2/8 (25%), 10/50 (20%), 5/9 (56%), 6/56 (11%)), stent movement (1/8 (13%), 4/50 (8%), 0/9 (0%), 4/56 (7%)), procedural complications (1/9 (11%), 7/66 (11%), 2/11 (18%), 2/70 (3%)) and immediate near complete aneurysm occlusion (6/6 (100%), 24/37 (65%), 5/7 (71%), 40/45 (89%)) trended towards improvement with each generation. Improvements in difficult stent placement and immediate aneurysm occlusion were significant (p=0.01 and 0.03, respectively). Conclusion: Neuroform stent-assisted coiling has evolved through four generations as a safe and effective means of treating wide-necked intracranial aneurysms.
机译:背景与目的:自2002年以来,Neuroform支架就扩大了颈内动脉瘤的血管内治疗范围。进行了一项研究,以评估使用Neuroform 1、2、2 Treo和3进行支架辅助卷绕的技术成功率以及血管造影和临床结果。方法:将接受Neuroform支架辅助卷绕的患者纳入包括156个支架的前瞻性注册表中连续113位患者(平均年龄53,范围25-78)进行部署。使用对数似然比χ2检验比较了Neuroform 1、2、2 Treo和3支架在血管造影随访中的部署成功和困难,支架移动,手术并发症,立即/延迟的动脉瘤闭塞和支架内狭窄。结果:在156次支架尝试中,部署了123次(79%)(神经形态1:8/9(89%),神经形态2:50/66(76%),神经形态2 Treo:9/11(82%),神经形态3:56/70(80%)),症状并发症率为1.9%(3/156; 2次短暂性脑缺血发作,1例中风,无死亡)。非目标支架放置(1/8(13%),6/50(12%),2/9(22%),3/56(5%)),困难放置(2/8(25%), 10/50(20%),5/9(56%),6/56(11%)),支架移动(1/8(13%),4/50(8%),0/9(0% ),4/56(7%)),手术并发症(1/9(11%),7/66(11%),2/11(18%),2/70(3%))和立即接近完成动脉瘤闭塞(6/6(100%),24/37(65%),5/7(71%),40/45(89%))趋于随着每一代的改善。困难的支架置入和立即的动脉瘤闭塞的改善显着(分别为p = 0.01和0.03)。结论:神经形态支架辅助卷绕技术已经发展了四代,是一种安全有效的治疗宽颈颅内动脉瘤的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号